AAD 2026视频特辑
皮科洞见
中国发表|不同β细胞功能水平下,iGlarLixi较IDegAsp治疗2型糖尿病展现更优疗效与安全性
拓麦Diabetes | 2026-01-15
Copyright (C) 2026 by eDoctor Healthcare Communications. All Rights Reserved.
沪公网安备31010502003091号 | 沪ICP备11005620号-15